美團點評(3690.HK)再創上市新高價 市值位居港股市場第13位
格隆匯5月20日丨入選了格隆匯2020年“下注中國十大核心資產”名單的美團點評(3690.HK)今日跳空上漲再創上市新高價128.6港元,截至半日收盤報128港元,最新總市值7458億港元。該股年內累漲25.61%。恆指公司董事兼研究及分析主管黃偉雄稱,以現時數據,阿里、小米、美團3家同股不同權公司都符合基本納入要求,但最終能否納入要視乎未來數月表現和8月季檢計分機制。恆指有快速納入機制,若市值為港股市場首5位,最快香港上市3個月就可納入,市值在25名以內,18個月或更短時間,就能納入。美團點評目前7458億港元的市值位居港股市場第13位。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.